NDC properties for NDC 9 0299-6100
NDC item 00299610010
| NDC 9 | 0299-6100 |
|---|---|
| NDC 10 | 0299-6100-10 |
| NDC Item | 00299610010 |
| packaging | 1 TUBE in 1 CARTON (0299-6100-10) / 100 g in 1 TUBE |
| FDA SPL set id | 127914 |
| Labeler | Galderma Laboratories, L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2017-05-03 |
| Marketing effective time low | 2006-06-29 |
| Marketing status | COMPLETED |
| NDA | NDA021717 |
NDC item 00299610035
| NDC 9 | 0299-6100 |
|---|---|
| NDC 10 | 0299-6100-35 |
| NDC Item | 00299610035 |
| packaging | 1 TUBE in 1 CARTON (0299-6100-35) / 30 g in 1 TUBE |
| FDA SPL set id | 127914 |
| Labeler | Galderma Laboratories, L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2017-05-03 |
| Marketing effective time low | 2006-06-29 |
| Marketing status | COMPLETED |
| NDA | NDA021717 |
NDC item 51672530502
| NDC 9 | 51672-5305 |
|---|---|
| NDC 10 | 51672-5305-2 |
| NDC Item | 51672530502 |
| packaging | 1 TUBE in 1 CARTON (51672-5305-2) / 30 g in 1 TUBE |
| FDA SPL set id | 540569 |
| Labeler | Taro Pharmaceuticals U.S.A., Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2018-12-11 |
| Marketing status | ACTIVE |
| NDA | NDA021717 |
NDC item 73575000902
| NDC 9 | 73575-009 |
|---|---|
| NDC 10 | 73575-009-02 |
| NDC Item | 73575000902 |
| packaging | 2 TUBE in 1 CARTON (73575-009-02) / 30 g in 1 TUBE |
| FDA SPL set id | 500476 |
| Labeler | Oba Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-01-24 |
| Marketing status | ACTIVE |
| NDA | NDA021717 |
NDC item 73575000904
| NDC 9 | 73575-009 |
|---|---|
| NDC 10 | 73575-009-04 |
| NDC Item | 73575000904 |
| packaging | 4 TUBE in 1 CARTON (73575-009-04) / 30 g in 1 TUBE |
| FDA SPL set id | 500476 |
| Labeler | Oba Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-01-24 |
| Marketing status | ACTIVE |
| NDA | NDA021717 |
NDC item 73575000909
| NDC 9 | 73575-009 |
|---|---|
| NDC 10 | 73575-009-09 |
| NDC Item | 73575000909 |
| packaging | 1 TUBE in 1 CARTON (73575-009-09) / 30 g in 1 TUBE |
| FDA SPL set id | 500476 |
| Labeler | Oba Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-01-24 |
| Marketing status | ACTIVE |
| NDA | NDA021717 |